These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 24461766

  • 1. Quantification of myocardial iron deficiency in nonischemic heart failure by cardiac T2* magnetic resonance imaging.
    Nagao M, Matsuo Y, Kamitani T, Yonezawa M, Yamasaki Y, Kawanami S, Abe K, Mukai Y, Higo T, Yabuuchi H, Takemura A, Yoshiura T, Sunagawa K, Honda H.
    Am J Cardiol; 2014 Mar 15; 113(6):1024-30. PubMed ID: 24461766
    [Abstract] [Full Text] [Related]

  • 2. Myocardial triglyceride content at 3 T cardiovascular magnetic resonance and left ventricular systolic function: a cross-sectional study in patients hospitalized with acute heart failure.
    Liao PA, Lin G, Tsai SY, Wang CH, Juan YH, Lin YC, Wu MT, Yang LY, Liu MH, Chang TC, Lin YC, Huang YC, Huang PC, Wang JJ, Ng SH, Ng KK.
    J Cardiovasc Magn Reson; 2016 Feb 05; 18():9. PubMed ID: 26850626
    [Abstract] [Full Text] [Related]

  • 3. Correlation between extent of myocardial fibrosis assessed by cardiac magnetic resonance and cardiac troponin T release in patients with nonischemic heart failure.
    Takashio S, Yamamuro M, Uemura T, Utsunomiya D, Morita K, Izumiya Y, Sugiyama S, Kojima S, Yamamoto E, Tsujita K, Tanaka T, Tayama S, Kaikita K, Hokimoto S, Yasuda O, Yamashita Y, Ogawa H.
    Am J Cardiol; 2014 May 15; 113(10):1697-704. PubMed ID: 24698466
    [Abstract] [Full Text] [Related]

  • 4. The relationship between the myocardial T2* value and left ventricular volumetric and functional parameters in thalassemia major patients.
    Bayraktaroğlu S, Aydinok Y, Yildiz D, Uluer H, Savaş R, Alper H.
    Diagn Interv Radiol; 2011 Dec 15; 17(4):346-51. PubMed ID: 21647857
    [Abstract] [Full Text] [Related]

  • 5. Value of early cardiovascular magnetic resonance for the prediction of adverse arrhythmic cardiac events after a first noncomplicated ST-segment-elevation myocardial infarction.
    Izquierdo M, Ruiz-Granell R, Bonanad C, Chaustre F, Gomez C, Ferrero A, Lopez-Lereu P, Monmeneu JV, Nuñez J, Chorro FJ, Bodi V.
    Circ Cardiovasc Imaging; 2013 Sep 15; 6(5):755-61. PubMed ID: 23926195
    [Abstract] [Full Text] [Related]

  • 6. Relationship between myocardial T2 values and cardiac volumetric and functional parameters in β-thalassemia patients evaluated by cardiac magnetic resonance in association with serum ferritin levels.
    Liguori C, Pitocco F, Di Giampietro I, de Vivo AE, Schena E, Cianciulli P, Zobel BB.
    Eur J Radiol; 2013 Sep 15; 82(9):e441-7. PubMed ID: 23639773
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of pulmonary vascular resistance estimated by cardiac magnetic resonance in patients with chronic heart failure.
    Fabregat-Andrés Ó, Estornell-Erill J, Ridocci-Soriano F, García-González P, Bochard-Villanueva B, Cubillos-Arango A, Espriella-Juan Rde L, Fácila L, Morell S, Cortijo J.
    Eur Heart J Cardiovasc Imaging; 2014 Dec 15; 15(12):1391-9. PubMed ID: 25104808
    [Abstract] [Full Text] [Related]

  • 8. Is cardiac and hepatic iron status assessed by MRI T2* associated with left ventricular function in patients with idiopathic cardiomyopathy?
    Kanzaki Y, Yuki M, Yamamura KI, Narumi Y, Ishizaka N.
    Heart Vessels; 2016 Dec 15; 31(12):1950-1959. PubMed ID: 26897743
    [Abstract] [Full Text] [Related]

  • 9. Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy.
    Bello D, Shah DJ, Farah GM, Di Luzio S, Parker M, Johnson MR, Cotts WG, Klocke FJ, Bonow RO, Judd RM, Gheorghiade M, Kim RJ.
    Circulation; 2003 Oct 21; 108(16):1945-53. PubMed ID: 14557364
    [Abstract] [Full Text] [Related]

  • 10. End-systolic wall stress predicts post-discharge heart failure after acute myocardial infarction.
    Clerfond G, Bière L, Mateus V, Grall S, Willoteaux S, Prunier F, Furber A.
    Arch Cardiovasc Dis; 2015 May 21; 108(5):310-20. PubMed ID: 25858536
    [Abstract] [Full Text] [Related]

  • 11. Effect of iron overload on exercise capacity in thalassemic patients with heart failure.
    Mavrogeni S, Gotsis E, Verganelakis D, Berdousis E, Dritsas A, Kolovou G, Toulas P, Ladis V.
    Int J Cardiovasc Imaging; 2009 Dec 21; 25(8):777-83. PubMed ID: 19680779
    [Abstract] [Full Text] [Related]

  • 12. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
    Bruder O, Breuckmann F, Jensen C, Jochims M, Naber CK, Barkhausen J, Erbel R, Sabin GV, Herzinfarktverbund Essen.
    Herz; 2008 Mar 21; 33(2):136-42. PubMed ID: 18344033
    [Abstract] [Full Text] [Related]

  • 13. Delayed hyperenhancement magnetic resonance imaging is useful in predicting functional recovery of nonischemic left ventricular systolic dysfunction.
    Park S, Choi BW, Rim SJ, Shim CY, Ko YG, Kang SM, Ha JW, Jang Y, Chung N, Choe KO, Cho SY.
    J Card Fail; 2006 Mar 21; 12(2):93-9. PubMed ID: 16520255
    [Abstract] [Full Text] [Related]

  • 14. Intraventricular dyssynchrony predicts mortality and morbidity after cardiac resynchronization therapy: a study using cardiovascular magnetic resonance tissue synchronization imaging.
    Chalil S, Stegemann B, Muhyaldeen S, Khadjooi K, Smith RE, Jordan PJ, Leyva F.
    J Am Coll Cardiol; 2007 Jul 17; 50(3):243-52. PubMed ID: 17631217
    [Abstract] [Full Text] [Related]

  • 15. Cardiac iron removal and functional cardiac improvement by different iron chelation regimens in thalassemia major patients.
    Cassinerio E, Roghi A, Pedrotti P, Brevi F, Zanaboni L, Graziadei G, Pattoneri P, Milazzo A, Cappellini MD.
    Ann Hematol; 2012 Sep 17; 91(9):1443-9. PubMed ID: 22572843
    [Abstract] [Full Text] [Related]

  • 16. Native Myocardial T1 as a Biomarker of Cardiac Structure in Non-Ischemic Cardiomyopathy.
    Shah RV, Kato S, Roujol S, Murthy V, Bellm S, Kashem A, Basha T, Jang J, Eisman AS, Manning WJ, Nezafat R.
    Am J Cardiol; 2016 Jan 15; 117(2):282-8. PubMed ID: 26684511
    [Abstract] [Full Text] [Related]

  • 17. Thoracic spinal cord stimulation improves cardiac contractile function and myocardial oxygen consumption in a porcine model of ischemic heart failure.
    Liu Y, Yue WS, Liao SY, Zhang Y, Au KW, Shuto C, Hata C, Park E, Chen P, Siu CW, Tse HF.
    J Cardiovasc Electrophysiol; 2012 May 15; 23(5):534-40. PubMed ID: 22151312
    [Abstract] [Full Text] [Related]

  • 18. Magnetic resonance imaging assessment of intraventricular dyssynchrony and delayed enhancement as predictors of response to cardiac resynchronization therapy in patients with heart failure of ischaemic and non-ischaemic etiologies.
    Petryka J, Miśko J, Przybylski A, Śpiewak M, Małek ŁA, Werys K, Mazurkiewicz Ł, Gepner K, Croisille P, Demkow M, Rużyłło W.
    Eur J Radiol; 2012 Oct 15; 81(10):2639-47. PubMed ID: 22056486
    [Abstract] [Full Text] [Related]

  • 19. Predictors of super-response to cardiac resynchronization therapy and associated improvement in clinical outcome: the MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy) study.
    Hsu JC, Solomon SD, Bourgoun M, McNitt S, Goldenberg I, Klein H, Moss AJ, Foster E, MADIT-CRT Executive Committee.
    J Am Coll Cardiol; 2012 Jun 19; 59(25):2366-73. PubMed ID: 22698490
    [Abstract] [Full Text] [Related]

  • 20. Cardiac magnetic resonance postcontrast T1 time is associated with outcome in patients with heart failure and preserved ejection fraction.
    Mascherbauer J, Marzluf BA, Tufaro C, Pfaffenberger S, Graf A, Wexberg P, Panzenböck A, Jakowitsch J, Bangert C, Laimer D, Schreiber C, Karakus G, Hülsmann M, Pacher R, Lang IM, Maurer G, Bonderman D.
    Circ Cardiovasc Imaging; 2013 Nov 19; 6(6):1056-65. PubMed ID: 24036385
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.